FinalDose
YC X26London, GB · Founded 2025 · 5 employees · 2 known investors
FinalDose develops a programmable DNA-targeting molecule designed to recognize and destroy cells carrying specific genetic sequences, with initial applications in oncology across cancer types.
AI & Machine LearningBiotechHealthtechArtificial IntelligenceGene TherapyTherapeuticsGenetic Engineeringin /finaldose/@LaunchFD2026